{"nct_id":"NCT02621892","title":"A 12-Week Study With a 4-Week Randomized Withdrawal Period to Evaluate the Efficacy and Safety of Tenapanor for the Treatment of IBS-C","status":"COMPLETED","status_verified_date":"2020-04","start_date":"2015-10","start_date_type":null,"primary_completion_date":"2017-03","primary_completion_date_type":"ACTUAL","completion_date":"2017-04","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["ARDX"]}